Uncovering Opportunity in MedTech

Serial Medtech entrepreneur, Steve Arless talks about uncovering opportunity for a better management of calcium in the cardiovascular system. And that the interventional world was starting to realize that the real problem is calcium, not plaque.

Full interview at @Starfish Medical

Steve Arless talks about his entrepreneurial career and strategies from three successful cardiovascular startups: CryCath, CardioInsight, and SoundBite, in his Medtech Adventures interview with Scott Phillips. Currently the MedTech Entrepreneur-in-Residence at Centech, Steve has directed and created several medical device companies, from inception to major financing and public stock offerings, in addition to advancing new medical devices from R&D to commercialization and global sales marketing.

Steve has served as CEO for a number of companies, most notably CryoCath Technologies (sold to Medtronic Inc. for $400 million CAD), Resonant Medical (sold to Elekta AB for $30 million), and CardioInsight (also sold to Medtronic for $100 million USD).